Pregabalin [PGB, (S)-3-isobutyl GABA, CI-1008] is a derivative of the inhib
itory neurotransmitter g-aminobutyric acid (GABA). It has shown anticonvuls
ant, analgesia and anxiety activity in animal models. In this report, blood
-brain barrier (BBB) influx and efflux of PGB were investigated with microd
ialysis at efficacious doses in rats.'
BBB influx (CLin) and efflux (CLout) permeability for pregabalin were 4.8 a
nd 37.2 muL/min/g brain, respectively, following an intravenous infusion to
rats. The results indicate that PGB is brain penetrable, supporting its an
ti-epilepsy and other CNS pharmacology. Significant anticonvulsant action o
f PGB was detected between 2 and 8 hr post oral dose, which is lag behind E
CF drug concentrations lees. A PK/PD link model was used to describe the co
unter-clockwise hysteresis relationship between pregabalin brain ECF concen
tration and the anticonvulsant effect in rats. The resulting C-e (concentra
tion in effect compartment) versus effect profile exhibits a sigmoidal curv
e and the calculated ECe50 and K-eo values were 95.3 ng/mL and 0.0092 min-1
, respectively. The small K-eo value suggests that the effect is not direct
ly proportional to the amount of pregabalin in the ECF compartment possibly
due to inherent delay.